Skip to main content
SpringerLink
Log in

Introduction and Historical Perspective on Experimental Myocarditis

  • Chapter
Myocarditis

  • 200 Accesses

Abstract

During the last half century, funds for research and advances in technology permitted cardiologists, immunologists, infectious disease researchers, pathologists, and virologists to make significant progress in understanding how numerous infectious agents, including bacteria, fungi, and viruses, can induce myocarditis in humans. Although more than 20 common viruses have been associated with myocarditis in humans, serologic evidence indirectly suggested that enteroviruses classified as the coxsackieviruses group B (CVB), particularly serotypes B1–B5, were the major etiologic agents of this inflammatory heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dalldorf G, Sickles GM. Unidentified filtrable agent isolated from feces of children with paralysis. Science 1948;108:61–62.

    Article  PubMed  CAS  Google Scholar 

  2. Melnick JL, Shaw EW, Curnen EC. Virus isolated from patients diagnosed as non-paralytic poliomyelitis or aseptic meningitis. Proc Soc Exp Biol Med 1949;71:344–349.

    PubMed  CAS  Google Scholar 

  3. Gifford R, Dalldorf G. Morbid anatomy of experimental coxsackie virus infection. Am J Pathol 1951;27:1047–1063.

    PubMed  CAS  Google Scholar 

  4. Crowell RL, Landau BJ. A short history and introductory background on the coxsackieviruses of group B. Curr Top Microbiol Immunol 1997;223:1–11.

    Article  PubMed  CAS  Google Scholar 

  5. Enders JF, Weller TH, Robbins FC. Cultivation of Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 1949;109:85–87.

    Article  PubMed  CAS  Google Scholar 

  6. Kilbourne ED, Horsfall FL Jr. Lethal infection with coxsackie virus of adult mice given cortisone. Proc Soc Exp Biol Med 1951;77:135–138.

    PubMed  CAS  Google Scholar 

  7. Committee on the Enteroviruses. The enteroviruses. Am J Public Health 1957;47:1556–1566.

    Article  Google Scholar 

  8. Melnick JL, Cockburn WC, Dalldorf G, Gard S, Gear JHS, Hammon WMcD, Kaplan MM, Nagler FP, Oker-Blom N, Rhodes AJ, Sabin AB, Verlinde JD, von Magnus H. Picornavirus group. Virology 1963;19:114–116.

    Article  Google Scholar 

  9. Melnick JL. Classification and nomenclature of viruses, 1973. Prog Med Virol 1973;16:337–342.

    PubMed  CAS  Google Scholar 

  10. Fenner F. Classification and nomenclature of viruses. Second report of the International Committee on Taxonomy of Viruses. Intervirology 1976;7:1–115.

    Article  Google Scholar 

  11. Burch GE, Giles TD. The role of viruses in the production of heart disease. Am J Cardiol 1972;29:231–240.

    Article  PubMed  CAS  Google Scholar 

  12. Burch GE, Sun SC, Colcolough HL, Sohal RS, DePasquale NP. Coxsackie B viral myocarditis and valvulitis identified in routine autopsy specimens by immunofluorescent techniques. Am Heart J 1967;74:13–23.

    Article  PubMed  CAS  Google Scholar 

  13. Burch GE, Sun SC, Chu KC, Sohal RS, Colcolough HL. Interstitial and coxsackievirus B myocarditis in infants and children. A comparative histologic and immunofluorescent study of 50 autopsied hearts. JAMA 1968;203:1–8.

    Article  PubMed  CAS  Google Scholar 

  14. Connolly JH. Myocarditis during coxsackie B5 infection. Br Med J 1961;1:877–878.

    Article  PubMed  CAS  Google Scholar 

  15. Gear JH. Coxsackie virus infections of the newborn. Prog Med Virol 1958;1:106–121.

    PubMed  CAS  Google Scholar 

  16. Gear JHS, Measroch V. Coxsackievirus infections of the newborn. Prog Med Virol 1973;15:42–62.

    PubMed  CAS  Google Scholar 

  17. Grist NR, Bell EJ. Coxsackie viruses and the heart. Am Heart J 1969;77:295–300.

    Article  PubMed  CAS  Google Scholar 

  18. Helin M, Savola J, Lapinleimu K. Cardiac manifestations during a Coxsackie B5 epidemic. Br Med J 1968;3:97–99.

    Article  PubMed  CAS  Google Scholar 

  19. Hirschman SZ, Hammer GS. Coxsackie virus myopericarditis. A microbiological and clinical review. Am J Cardiol 1974;34:224–232.

    Article  PubMed  CAS  Google Scholar 

  20. Hosier DM, Newton WA Jr. Serious coxsackie infection in infants and children. Am J Dis Child 1958;96:251–267.

    CAS  Google Scholar 

  21. Javett SN, Heymann S, Mundel B, Pepler WJ, Lurie HI, Gear J, Measroch V, Kirsch Z. Myocarditis in the newborn infant: a study of an outbreak associated with coxsackie group B virus infection in a maternity home in Johannesburg. J Pediatr 1956;48:1–22.

    Article  PubMed  CAS  Google Scholar 

  22. Kibrick S, Benirschke K. Acute aseptic myocarditis and meningoencephalitis in the newborn child infected with coxsackie virus group B, type 3. N Engl J Med 1956;255:883–889.

    Article  PubMed  Google Scholar 

  23. Lansdown AB. Viral infections and diseases of the heart. Prog Med Virol 1978;24:70–113.

    PubMed  CAS  Google Scholar 

  24. Montgomery J, Gear J, Prinsloo FR, Kahn M, Kirsch ZG. Myocarditis of the newborn: an outbreak in a maternity home in Southern Rhodesia associated with coxsackie group-B virus infection. South African Med J 1955;29:608–612.

    CAS  Google Scholar 

  25. Nouaille J, Gautier M. Viral infections in which cardiovascular manifestations predominate. In: Debré R, Celers J, eds. Clinical virology: the evaluation and management of human viral infections. Philadelphia: WB Saunders Company, 1970:485–496.

    Google Scholar 

  26. Van Creveld S, de Jager H. Myocarditis in newborns, caused by coxsackie virus. Clinical and pathological data. Ann Paediatr 1956;187:100–112.

    Google Scholar 

  27. Gauntt CJ, Gomez PT, Duffey PS, Grant JA, Trent DW, Witherspoon SM, Paque RE. Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol 1984;52:598–605.

    PubMed  CAS  Google Scholar 

  28. Gauntt CJ, Trousdale MD, LaBadie DR, Paque RE, Nealon T. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol 1979;3:207–220.

    Article  PubMed  CAS  Google Scholar 

  29. Paque RE, Gauntt CJ, Nealon TJ, Trousdale MD. Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol 1978;120:1672–1678.

    PubMed  CAS  Google Scholar 

  30. Paque RE, Straus DC, Nealon TJ, Gauntt CJ. Fractionation and immunologic assessment of KC 1extracted cardiac antigens in coxsackievirus B3 virus-induced myocarditis. J Immunol 1979;123:358–364.

    PubMed  CAS  Google Scholar 

  31. Rabin ER, Hassan SA, Jenson AB, Melnick JL. Coxsackie virus B3 myocarditis in mice. An electron microscopic, immunofluorescent and virus-assay study. Am J Pathol 1964;44:775–797.

    PubMed  CAS  Google Scholar 

  32. Reyes MP, Smith FE, Lerner AM. An enterovirus-induced murine model of an acute dilated-type cardiomyopathy. Intervirology 1984;22:146–155.

    Article  PubMed  CAS  Google Scholar 

  33. Rytel MW, Kilbourne ED. Differing susceptibility of adolescent and adult mice to non-lethal infection with coxsackievirus B3. Proc Soc Exp Biol Med 1971;137:443–448.

    Google Scholar 

  34. Hoshino T, Kawai C, Tokuda M. Experimental coxsackie B viral myocarditis in cynomolgus monkeys. Jpn Circ J 1983;47:59–66.

    Article  PubMed  CAS  Google Scholar 

  35. Horita H, Kitaura Y, Deguchi H, Kotaka M, Kawamura K. Experimental coxsackie B3 virus myocarditis in golden hamsters. II. Evaluation of left ventricular function in intact in situheart 14 months after inoculation. Jpn Circ J 1984;48:1097–1106.

    Article  Google Scholar 

  36. Paque RE, Gauntt CJ, Nealon TJ. Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio).Infect Immun 1981;31:470–479.

    PubMed  CAS  Google Scholar 

  37. Rhodes AJ, Van Rooyen CE. Textbook of virology: for students and practitioners of medicine and the other health sciences. 5th ed. Baltimore: Williams &Wilkins Company, 1968:129–131.

    Google Scholar 

  38. Pallansch MA. Epidemiology of group B coxsackieviruses. In: Bendinelli M, Friedman H, eds. Coxsackieviruses: a general update. New York: Plenum Press, 1988:399–417.

    Chapter  Google Scholar 

  39. Mahy BWJ. Classification and general properties. In: Bendinelli M, Friedman H, eds. Coxsackieviruses: a general update. New York: Plenum Press, 1988:1–18.

    Chapter  Google Scholar 

  40. Gauntt CJ, Sakkinen P, Rose NR, Huber SA. Picornaviruses: immunopathology and autoimmunity. In: Cunningham MW, Fujinami RS, eds. Effects of microbes on the immune system. Philadelphia: Lippincott Williams & Wilkins, 2000:313–329.

    Google Scholar 

  41. Rueckert RR. Picornaviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE, eds. Fundamental virology. 3rd ed. Philadelphia: Lippincott-Raven, 1996:477–522.

    Google Scholar 

  42. Gauntt CJ. Cellular and humoral immune responses in coxsackievirus myocarditis. In: Kawai C, Abelmann WH, Matsumori A, eds. Pathogenesis of myocarditis and cardiomyopathy: recent experimental and clinical studies. Tokyo: University of Tokyo Press, 1987:49–61.

    Google Scholar 

  43. Gauntt CJ. Roles of the humoral response in coxsackievirus B-induced disease. Curr Top Microbiol Immunol 1997;223:259–282.

    Article  PubMed  CAS  Google Scholar 

  44. Leslie K, Blay R, Haisch C, Lodge A, Weller A, Huber S. Clinical and experimental aspects of viral myocarditis. Clin Microbiol Rev 1989;2:191–203.

    PubMed  CAS  Google Scholar 

  45. Schwimmbeck PL, Huber SA, Schultheiss HP. Roles of T cells in coxsackievirus B-induced disease. Curr Top Microbiol Immunol 1997;223:283–303.

    Article  PubMed  CAS  Google Scholar 

  46. Gauntt C, Higdon A, Bowers D, Maull E, Wood J, Crawley R. What lessons can be learned from animal model studies in viral heart disease? Scand J Infect Dis Suppl 1993;88:49–65.

    PubMed  CAS  Google Scholar 

  47. Huber SA, Job LP, Auld KR, Woodruff JF. Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during Coxsackievirus B-3 infection. J Immunol 1981;126:1336–1340.

    PubMed  CAS  Google Scholar 

  48. Loria RM. Host conditions affecting the course of coxsackievirus infections. In: Bendinelli M, Friedman H, eds. Coxsackieviruses: a general update. New York: Plenum Press, 1988:135–157.

    Chapter  Google Scholar 

  49. Wong CY, Woodruff JJ, Woodruff JF. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. III. Role of sex. J Immunol 1977;119:591–597.

    PubMed  CAS  Google Scholar 

  50. Woodruff JF. Viral myocarditis. A review. Am J Pathol 1980;101:425–484.

    PubMed  CAS  Google Scholar 

  51. Chapman NM, Ramsingh AI, Tracy S. Genetics of coxsackievirus virulence. Curr Top Microbiol Immunol 1997;223:227–258.

    Article  PubMed  CAS  Google Scholar 

  52. Lee C, Maull E, Chapman N, Tracy S, Gauntt C. Genomic regions of coxsackievirus B3 associated with cardiovirulence. J Med Virol 1997;52:341–347.

    Article  PubMed  CAS  Google Scholar 

  53. Gauntt CJ. The possible role of viral variants in pathogenesis. In: Bendinelli M, Friedman H, eds. Coxsackieviruses: a general update. New York: Plenum Press, 1988:159–179.

    Chapter  Google Scholar 

  54. Gauntt CJ, Godeny EK, Lutton CW, Arizpe HM, Chapman NM, Tracy SM, Revtyak GE, Valente AJ, Rozek MM. Mechanism(s) of coxsackievirus-induction of acute myocarditis in a mouse model. In: de la Maza LM, Peterson EM, eds. Medical virology VIII. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988:161–182.

    Google Scholar 

  55. Reyes MP, Lerner AM. Coxsackievirus myocarditis-with special reference to acute and chronic effects. Prog Cardiovasc Dis 1985;27:373–394.

    Article  PubMed  CAS  Google Scholar 

  56. Loria RM, Kibrick S, Broitman SA. Peroral infection with group B coxsackievirus in the newborn mouse: a model for human infection. J Infect Dis 1974;130:225–230.

    Article  PubMed  CAS  Google Scholar 

  57. Gauntt CJ, Godeny EK, Lutton CW. Host factors regulating viral clearance. Pathol Immunopathol Res 1988;7:251–265.

    Article  PubMed  CAS  Google Scholar 

  58. Abelmann WH. Virus and the heart. Circulation 1971;44:950–956.

    Article  PubMed  CAS  Google Scholar 

  59. McManus BM, Cassling RS, Gauntt CJ. Immunologic basis of myocardial injury. Cardiovasc Clin 1986;18:163–184.

    Google Scholar 

  60. Anderson DR, Wilson JE, Carthy CM, Yang D, Kandolt R, McManus 3M. Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol 1996;70:4632–4645.

    PubMed  CAS  Google Scholar 

  61. Klingel K, Stephan S, Sauter M, Zell R, McManus BM, Bultmann B, Kandolf R. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol 1996;70:8888–8895.

    PubMed  CAS  Google Scholar 

  62. Gauntt CJ, Paque RE, Trousdale MD, Gudvangen RJ, Barr DT, Lipotich GJ, Nealon TJ, Duffey PS. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect Immun 1983;39:851–864.

    PubMed  CAS  Google Scholar 

  63. Godeny EK, Gauntt CJ. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol 1986;137:1695–1702.

    PubMed  CAS  Google Scholar 

  64. Lutton CW, Gauntt CJ. Ameliorating effect of IFN-ß3 and anti-IFN-ß3 on coxsackievirus B3-induced myocarditis in mice. J Interferon Res 1985;5:137–146.

    Article  PubMed  CAS  Google Scholar 

  65. Godeny EK, Gauntt CJ. Murine natural killer cells limit coxsackievirus B3 replication. J Immunol 1987;139:913–918.

    PubMed  CAS  Google Scholar 

  66. Godeny EK, Gauntt CJ. In situimmune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis. Am J Pathol 1987;129:267–276.

    PubMed  CAS  Google Scholar 

  67. Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz A. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 1996;97:1837–1843.

    Article  PubMed  CAS  Google Scholar 

  68. Freeman GL, Colston JT, Zabalgoitia M, Chandrasekar B. Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. Am J Physiol 1998;274(1 Pt 2): H249–H258.

    PubMed  CAS  Google Scholar 

  69. Martino TA, Liu P, Petric M, Sole MJ. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. In: Rotbart HA, ed. Human enterovirus infections. Washington, DC: ASM Press, 1995:291–351.

    Google Scholar 

  70. Grist NR, Bell EJ, Assaad F. Enteroviruses in human disease. Prog Med Virol 1978;24:114–157.

    PubMed  CAS  Google Scholar 

  71. Kogon A, Spigland I, Frothingham TE, Elveback L, Williams C, Hall CE, Fox JP. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am J Epidemiol 1969;89:51–61.

    PubMed  CAS  Google Scholar 

  72. Lau RC. Coxsackie B virus infections in New Zealand patients with cardiac and non-cardiac diseases. J Med Virol 1983;11:131–137.

    Article  PubMed  CAS  Google Scholar 

  73. Roggendorf M. Experience with enzyme-linked immunosorbent assay for the detection of antibodies of the IgM class against coxsackie B viruses. In: Bolte H-D, ed. Viral heart disease. Berlin: Springer-Verlag, 1984:116–123.

    Chapter  Google Scholar 

  74. Cho CT, Feng KK, McCarthy VP, Lenahan ME Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer. Infect Immun 1982;37:720–727.

    PubMed  CAS  Google Scholar 

  75. Rager-Zisman B, Allison AC. The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol 1973;19:329–338.

    Article  PubMed  CAS  Google Scholar 

  76. Takada H, Kishimoto C, Hiraoka Y. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects. Circulation 1995;92:1604–1611.

    Article  PubMed  CAS  Google Scholar 

  77. Godney EK, Arizpe HM, Gauntt CJ. Characterization of the antibody response in vaccinated mice protected against coxsackievirus B3-induced myocarditis. Viral Immunol 1987–1988;1:305–314.

    Google Scholar 

  78. Herskowitz A, Beisel KW, Wolfgram LJ, Rose NR. Coxsackievirus B3 murine myocarditis: wide pathologic spectrum in genetically defined inbred strains. Hum Pathol 1985;16:671–673.

    Article  PubMed  CAS  Google Scholar 

  79. Herskowitz A, Wolfgram LJ, Rose NR, Beisel KW.. Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am Coll Cardiol 1987;9:1311–1319.

    Article  PubMed  CAS  Google Scholar 

  80. Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR. Variations in the susceptibility to coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol 1986;136:1846–1852.

    PubMed  CAS  Google Scholar 

  81. Wolfgram LJ, Rose NR. Coxsackievirus infection as a trigger of cardiac autoimmunity. Immunol Res 1989;8:61–80.

    Article  PubMed  CAS  Google Scholar 

  82. Huber SA, Pfaeffle B. Differential Th1and Th2cell responses in male and female BBALB/c mice infected with coxsackievirus group B type 3. J Virol 1994;68:5126–5132.

    PubMed  CAS  Google Scholar 

  83. Sato S, Tsutsumi R, Burke A, Carlson G, Porro V, Seko Y, Okumura K, Kawana R, Virmani R. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions. J Gen Virol 1994;75:2911–2924.

    Article  PubMed  CAS  Google Scholar 

  84. Maisch B. Cardiocytolysis by sera ofpatients suffering from acute perimyocarditis. In: Bolte H-D), ed. Viral heart disease. Berlin: Springer-Verlag, 1984:121–130.

    Chapter  Google Scholar 

  85. Maisch B. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute myocarditis and congestive cardiomyopathy. In: Chazov EI, Smirnov VN, Oganov RG, eds. Cardiology. London: Plenum, 1984:1327–1338.

    Google Scholar 

  86. Maisch B. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. Basic Res Cardiol 1986;81 Suppl 1:217–241.

    PubMed  Google Scholar 

  87. Maisch B. Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury. Springer Semin Immunopathol 1989;11:369–395.

    PubMed  CAS  Google Scholar 

  88. Maisch B. Myocarditis. Curr Opin Cardiol 1990;5:320–327.

    Article  Google Scholar 

  89. Maisch B, Berg PA, Kochsiek K. Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. Clin Exp Immunol 1979;38:189–197.

    PubMed  CAS  Google Scholar 

  90. Maisch B, Berg PA, Kochsiek K. Autoantibodies and serum inhibition factors (SIF) in patients with myocarditis. Klin Wochenschr 1980;58:219–225.

    Article  PubMed  CAS  Google Scholar 

  91. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983;52:1072–1078.

    Article  PubMed  CAS  Google Scholar 

  92. Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 1982;48:533–545.

    PubMed  CAS  Google Scholar 

  93. Maisch B, Bauer E, Cirsi M, Kochsiek K. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis: characterization and pathogenetic relevance. Circulation 1993;87 Suppl 4:49–65.

    Google Scholar 

  94. Maisch B, Outzen H, Roth D, Hiby A, Herzum M, Hengstenberg C, Hufnagel G, Schönian U, Kochsiek K. Prognostic determinants in conventionally treated myocarditis and perimyocarditisfocus on antimyolemmal antibodies. Eur Heart J 1991;12 Suppl D:81–87.

    Article  PubMed  Google Scholar 

  95. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990;16:839–846.

    Article  PubMed  CAS  Google Scholar 

  96. Rose NR, Herskowitz A, Neumann DA, Neu N. Autoimmune myocarditis: a paradigm of postinfection autoimmune disease. Immunol Today 1988;9:117–120.

    Article  PubMed  CAS  Google Scholar 

  97. Rose NR, Neumann DA, Herskowitz A. Coxsackievirus myocarditis. Adv Intern Med 1992;37:411–429.

    PubMed  CAS  Google Scholar 

  98. Schultheiss HP. The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy-clinical and experimental data. Springer Semin Immunopathol 1989;11:15–30.

    Article  PubMed  CAS  Google Scholar 

  99. Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985;17:603–617.

    Article  PubMed  CAS  Google Scholar 

  100. Schultheiss H-P, Schulze K, Kühl U, Ulrich G, Klingenberg M. The ADP/ATP carrier as a mitochondrial auto-antigen-facts and perspectives. Ann NY Acad Sci 1986;488:44–63.

    Article  PubMed  CAS  Google Scholar 

  101. Schulze K, Becker BF, Schultheiss HP. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo.Circ Res 1989;64:179–192.

    Article  PubMed  CAS  Google Scholar 

  102. Schwimmbeck PL, Schultheiss H-P, Strauer BE. Identification of a main autoimmunogenic epitope of the adenine nucleotide translocator which cross-reacts with coxsackie B3 virus: use in the diagnosis of myocarditis and dilative cardiomyopathy (abstract). Circulation 1989;80 Suppl 2:II-665.

    Google Scholar 

  103. Schwimmbeck PL, Schwimmbeck NK, Schultheiss HP, Strauer BE. Mapping of antigenic determinants of the adenine-nucleotide translocator and coxsackie B3 virus with synthetic peptides: use for the diagnosis of viral heart disease. Clin Immunol Immunopathol 1993;68:135–140.

    Article  PubMed  CAS  Google Scholar 

  104. Herskowitz A, Traystman MD, Beisel KW.. Murine viral myocarditis-new insights into mechanisms of disease. Heart Failure 1986;2:86–91.

    Google Scholar 

  105. Wolfgram LJ, Beisel KW, Rose NR. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med 1985;161:1112–1121.

    Article  PubMed  CAS  Google Scholar 

  106. Alvarez FL, Neu N, Rose NR, Craig SW, Beisel KW. Heart-specific autoantibodies induced by coxsackievirus B3: identification of heart autoantigens. Clin Immunol Immunopathol 1987;43:129–139.

    Article  PubMed  CAS  Google Scholar 

  107. Rose NR, Neumann DA, Herskowitz A, Traystman MD, Beisel KW.. Genetics of susceptibility to viral myocarditis in mice. Pathol Immunopathol Res 1988;7:266–278.

    Article  PubMed  CAS  Google Scholar 

  108. Neu N, Beisel KW, Traystman MD, Rose NR, Craig SW.. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to coxsackievirus B3-induced myocarditis. J Immunol 1987;138:2488–2492.

    PubMed  CAS  Google Scholar 

  109. Neumann DA, Lane JR, LaFond-Walker A, Allen GS, Wulff SM, Herskowitz A, Rose NR. Heartspecific autoantibodies can be eluted from the hearts of coxsackievirus B3-infected mice. Clin Exp Immunol 1991;86:405–412.

    Article  PubMed  CAS  Google Scholar 

  110. Neumann DA, Rose NR, Ansari AA, Herskowitz A. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. J Immunol 1994;152:343–350.

    PubMed  CAS  Google Scholar 

  111. Beisel KW, Rose NR. Relationship of coxsackievirus to cardiac autoimmunity. In: Bendinelli M, Friedman H, eds. Coxsackieviruses: a general update. New York: Plenum Press, 1988:271–292.

    Chapter  Google Scholar 

  112. Traystman MD, Beisel KW.. Genetic control of coxsackievirus B3-induced heart-specific autoantibodies associated with chronic myocarditis. Clin Exp Immunol 1991;86:291–298.

    Article  PubMed  CAS  Google Scholar 

  113. Huber SA, Lodge PA. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol 1986;122:284–291.

    PubMed  CAS  Google Scholar 

  114. Huber SA, Weller A, Herzum M, Lodge PA, Estrin M, Simpson K, Guthrie M. Immunopathogenic mechanisms in experimental picornavirus-induced autoimmunity. Pathol Immunopathol Res 1988;7:279–291.

    Article  PubMed  CAS  Google Scholar 

  115. Lodge PA, Herzum M, Olszewski J, Huber SA. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am J Pathol 1987;128:455–463.

    PubMed  CAS  Google Scholar 

  116. Gauntt CJ, Lutton CW, Arizpe HM, Higdon AH, Tracy SM. Autoimmune reactions in coxsackievirus B3-induced murine myocarditis. Life Sci Adv 1991;10:23–31.

    Google Scholar 

  117. Huber SA, Gauntt CJ, Sakkinen P. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res 1998;51:35–80.

    Article  PubMed  CAS  Google Scholar 

  118. Neu N, Craig SW, Rose NR, Alvarez F, Beisel KW.. Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol 1987;69:566–574.

    PubMed  CAS  Google Scholar 

  119. Weller AH, Simpson K, Herzum M, Van Houten N, Huber SA. Coxsackievirus-B3-induced mvocarditis: virus receptor antibodies modulate myocarditis. J Immunol 1989;143:1843–1850.

    PubMed  CAS  Google Scholar 

  120. Ulrich G, Kühl U, Melzner B, Janda I, Schäfer B, Schultheiss H-P. Antibodies against the adenosine di-/triphosphate carrier cross-react with the Ca channel-functional and biochemical data. In: Schultheiss H-P, ed. New concepts in viral heart disease: virology, immunology, and clinical management. Berlin: Springer-Verlag, 1988:225–235.

    Chapter  Google Scholar 

  121. Loudon RP, Moraska AF, Huber SA, Schwimmbeck P, Schultheiss P. An attenuated variant of coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.J Virol 1991;65:5813–5819.

    PubMed  CAS  Google Scholar 

  122. Gauntt CJ, Arizpe HM, Higdon AL, Rozek MM, Crawley R, Cunningham MW. Anti-coxsackievirus B3 neutralizing antibodies with pathological potential. Eur Heart J 1991;12 Suppl D:124–129.

    Google Scholar 

  123. Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, Crawley R. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol 1995;154:2983–2995.

    PubMed  CAS  Google Scholar 

  124. Gauntt CJ, Higdon AL, Arizpe HM, Tamayo MR, Crawley R, Henkel RD, Pereira ME, Tracy SM, Cunningham MW.. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin Immunol Immunopathol 1993;68:129–134.

    Article  PubMed  CAS  Google Scholar 

  125. Cunningham MW, Antone SM, Gullizia JM, McManus BM, Fischetti VA, Gauntt CJ. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A 1992;89:1320–1324.

    Article  PubMed  CAS  Google Scholar 

  126. Huber SA, Moraska A, Cunningham M. Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci. Proc Natl Acad Sci U S A 1994;91:5543–5547.

    Article  PubMed  CAS  Google Scholar 

  127. Fohlman J, Pauksen K, Morein B, Bjare U, Ilbäck N-G, Friman G. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand J Infect Dis Suppl 1993;88:103–108.

    PubMed  CAS  Google Scholar 

  128. Trousdale MD, Paque RE, Nealon T, Gauntt CJ. Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infect Immun 1979;23:486–495..

    Google Scholar 

  129. Gauntt CJ, Pallansch MA. Coxsackievirus 133 clinical isolates and murine myocarditis. Virus Kes 1996;41:89–99.

    Article  CAS  Google Scholar 

  130. Tracy S, Hofling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol 2000;62:70–81.

    Article  PubMed  CAS  Google Scholar 

  131. Beck MA, Chapman NM, McManus BM, Mullican JC, Tracy S. Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am J Pathol 1990;136:669–681.

    PubMed  CAS  Google Scholar 

  132. Huber SA, Job LP. Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3. Infect Immun 1983;39:1419–1427.

    PubMed  CAS  Google Scholar 

  133. Huber SA, Job LP, Woodruff JF. Lysis of infected myofibers by coxsackievirus B-3 immune T lymphocytes. Am J Pathol 1980;98:681–694.

    PubMed  CAS  Google Scholar 

  134. Lerner AM. Coxsackievirus myocardiopathy. J Infect Dis 1969;120:496–499.

    Article  PubMed  CAS  Google Scholar 

  135. Wong CY, Woodruff JJ, Woodruff JF. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity. J Immunol 1977;118:1159–1164.

    PubMed  CAS  Google Scholar 

  136. Wong CY, Woodruff JJ, Woodruff JF. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration of cytotoxicity against viral-infected myofibers. J Immunol 1977;118:1165–1169.

    PubMed  CAS  Google Scholar 

  137. Huber SA, Lodge PA. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am J Pathol 1984;116:21–29.

    PubMed  CAS  Google Scholar 

  138. Lerner AM, Wilson FM. Virus myocardiopathy. Prog Med Virol 1973;15:63–91.

    PubMed  CAS  Google Scholar 

  139. Huber SA. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab Invest 1997;76:691–701.

    PubMed  CAS  Google Scholar 

  140. Huber SA, Mortensen A, Moulton G. Modulation of cytokine expression by CD4+T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the γδ +T- cell receptor. J Virol 1996;70:3039–3044.

    PubMed  CAS  Google Scholar 

  141. Huber SA. Heat-shock protein induction in adriamycin and picornavirus-infected cardiocytes. Lab Invest 1992;67:218–224.

    PubMed  CAS  Google Scholar 

  142. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 1992;89:314–318.

    Article  PubMed  CAS  Google Scholar 

  143. Klingel K, Kandolf R. The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. Scand J Infect Dis Suppl 1993;88:79–85.

    PubMed  CAS  Google Scholar 

  144. Kishimoto C, Abelmann WH. In vivo significance of T cells in the development of coxsackievirus B3 myocarditis in mice: immature but antigen-specific T cells aggravate cardiac injury. Circ Res 1990;67:589–598.

    Article  PubMed  CAS  Google Scholar 

  145. Woodruff JF, Woodruff JJ. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J Immunol 1974;113:1726–1734.

    PubMed  CAS  Google Scholar 

  146. Guthrie M, Lodge PA, Huber SA. Cardiac injury in myocarditis induced by coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt2+ cytolytic lymphocytes. Cell Immunol 1984;88:558–567.

    Article  PubMed  CAS  Google Scholar 

  147. Huber SA, Stone JE, Wagner DH Jr, Kupperman J, Pfeiffer L, David C, O’Brien RL, Davis GS, Newell MK. γδ +T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J Virol 1999;73:5630–5636.

    PubMed  CAS  Google Scholar 

  148. Seko Y, Matsuda H, Kato K, Hashimoto Y, Yagita H, Okumura K, Yazaki Y. Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3. J Clin Invest 1993;91:1327–1336.

    Article  PubMed  CAS  Google Scholar 

  149. Henke A, Mohr C, Sprenger H, Graebner C, Stelzner A, Nain M, Gemsa D. Coxsackievirus B3induced production of tumor necrosis factor-a, IL-1ß, and IL-6 in human monocytes. J Immunol 1992;148:2270–2277.

    PubMed  CAS  Google Scholar 

  150. Huber SA, Polgar J, Schultheiss P, Schwimmbeck P. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol 1994;68:195–206.

    PubMed  CAS  Google Scholar 

  151. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 1993;151:1682–1690.

    PubMed  CAS  Google Scholar 

  152. Liu P. The role of cytokines in the pathogenesis of myocarditis. In: Schultheiss H-P, Schwimmbeck P, eds. The role of immune mechanisms in cardiovascular disease. Berlin: SpringerVerlag, 1997:44–56.

    Chapter  Google Scholar 

  153. Neumann DA, Lane JR, Allen GS, Herskowitz A, Rose NR. Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis? Clin Immunol Immunopathol 1993;68:181–190.

    Article  PubMed  CAS  Google Scholar 

  154. Gebhard JR, Perry CM, Harkins S, Lane T, Mena I, Asensio VC, Campbell IL, Whitton JL. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol 1998;153:417–428.

    Article  PubMed  CAS  Google Scholar 

  155. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O. Requirement of MIP.-lα for an inflammatory response to viral infection. Science 1995;269:1583–1585.

    Article  PubMed  CAS  Google Scholar 

  156. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N. Pancreatic expression of inter- feron- γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat me 2000:6:693–697.

    Article  CAS  Google Scholar 

  157. Tu Z, Chapman NM, Hufnagel G, Tracy S, Romero JR, Barry WH, Zhao L, Currey K, Shapiro B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J Virol 1995;69:4607–4618.

    PubMed  CAS  Google Scholar 

  158. Dunn JJ, Chapman NM, Tracy S, Romero JR. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. J Virol 2000;74:4787–4794.

    Article  PubMed  CAS  Google Scholar 

  159. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 1996;70:7811–7818.

    PubMed  CAS  Google Scholar 

  160. Khatib R, Probert A, Reyes MP, Khatib G, Chason JL. Mouse strain-related variation as a factor in the pathogenesis of coxsackievirus B3 murine myocarditis. J Gen Virol 1987;68:2981–2988.

    Article  PubMed  Google Scholar 

  161. Schnurr DP., Schmidt NJ. Persistent infections. In: Bendinelli M, Friedman H, eds. Coxsackieviruses: a general update. New York: Plenum Press, 1988:181–201.

    Chapter  Google Scholar 

  162. Baboonian C, Davies MJ, Booth JC, McKenna WJ. Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 1997;223:31–52.

    Article  PubMed  CAS  Google Scholar 

  163. Bowles NE, Richardson PJ, Olsen EG, Archard LC. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;1:1120–1123.

    Article  PubMed  CAS  Google Scholar 

  164. Easton AJ, Eglin RP. The detection of coxsackievirus RNA in cardiac tissue by in situhybridization. J Gen Virol 1988;69(Pt 2):285–291.

    Article  PubMed  CAS  Google Scholar 

  165. Hilton DA, Variend S, Pringle JH. Demonstration of coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situhybridization and the polymerase chain reaction. J Pathol 1993;170:45–51.

    Article  PubMed  CAS  Google Scholar 

  166. Kandolf R. The impact of recombinant DNA technology on the study of enterovirus heart disease. In: Bendinelli M, Friedman H, eds. Coxsackieviruses: a general update. New York: Plenum Press, 1988:293–318.

    Chapter  Google Scholar 

  167. Tracy S, Chapman NM, McManus BM, Pallansch MA, Beck MA, Carstens J. A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 1990:22:403–414.

    Article  PubMed  CAS  Google Scholar 

  168. Tracy S, Wiegand V, McManus B, Gauntt C, Pallansch M, Beck M, Chapman N. Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. J Am Coll Cardiol 1990;15:1688–1694.

    Article  PubMed  CAS  Google Scholar 

  169. Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990;82:8–16.

    Article  PubMed  CAS  Google Scholar 

  170. Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, Freeke CA, Archard LC. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994;89:2582–2589.

    Article  PubMed  CAS  Google Scholar 

  171. Wessely R, Henke A, Zell R, Kandolf R, Knowlton KU. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 1998;98:450–457.

    Article  PubMed  CAS  Google Scholar 

  172. Kerekatte V, Keiper BD, Badorff C, Cai A, Knowlton KU, Rhoads RE. Cleavage of poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? J Virol 1999;73:709–717.

    PubMed  CAS  Google Scholar 

  173. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999;5:320–326.

    Article  PubMed  CAS  Google Scholar 

  174. Beck MA, Levander OA. Effects of nutritional antioxidants and other dietary constituents on coxsackievirus-induced myocarditis. Curr Top Microbiol Immunol 1997;223:81–96.

    Article  PubMed  CAS  Google Scholar 

  175. Liu P, Aitken K, Kong YY, Opaysky MA, Martino T, Dawood F, Wen WH, Kozieradzki I, Bachmaier K, Straus D, Mak TW,, Penninger JM. The tyrosine kinase p56lckis essential in coxsackievirus B3-mediated heart disease. Nat Med 2000;6:429–434.

    Article  PubMed  CAS  Google Scholar 

  176. Yang D, Yu J, Luo Z, Carthy CM, Wilson JE, Liu Z, McManus BM. Viral myocarditis: identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart. Circ Res 1999;84:704–712.

    Article  PubMed  CAS  Google Scholar 

  177. Christian HA. Nearly ten decades of interest in idiopathic pericarditis. Am Heart J 1951;42:645–651.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Charles J. Gauntt Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

    Leslie T. Cooper Jr. MD (Consultant, Assistant Professor of Medicine) (Consultant, Assistant Professor of Medicine)

  2. Mayo Medical School, Rochester, Minnesota, USA

    Leslie T. Cooper Jr. MD (Consultant, Assistant Professor of Medicine) (Consultant, Assistant Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gauntt, C.J. (2003). Introduction and Historical Perspective on Experimental Myocarditis. In: Cooper, L.T. (eds) Myocarditis. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-319-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-319-4_1

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-366-4

  • Online ISBN: 978-1-59259-319-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation